We’re here for one reason and one reason only – to cure cancer. Every moment is dedicated to developing treatments and every action moves us one step closer to our goal. We’ve made incredible scientific breakthroughs and our pioneering personalized CAR T-cell therapies have changed the paradigm. But we're not finished yet.
Join Kite, as we make even bigger advances in cancer therapies, and help shape where our business and medical science goes next.
We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Kite and help create more tomorrows.
We are seeking a Director to lead our Potency Assay Development Team within Analytical Operations. The successful candidate will drive strategy and execution for potency assays supporting both cell therapy (e.g., CAR T) and gene therapy (e.g., viral vectors), including development, optimization, qualification/validation, and lifecycle management of mechanism-of-action (MOA)-relevant methods for clinical and commercial programs. This role partners closely with QC, Process Development, Manufacturing, Regulatory, and CMC to deliver assays that are fit for routine GMP release and stability testing, prioritizing robustness, control strategy, documentation, audit readiness, and to support comparability across process and site changes.
Reports to Senior Director, Analytical Development and Automation.
Responsibilities
Lead a high-performing technical team, fostering mentorship, scientific guidance, and career development.
Drive the development, optimization, and qualification/validation of potency assays for cell therapies (e.g., CAR T) and gene therapies (e.g., viral vectors) to support product release, stability, and characterization.
Ensure assay robustness, reproducibility, and transferability for commercial manufacturing through fit-for-purpose design, appropriate controls/standards, and statistically sound experimental design.
Oversee technical documentation (protocols, reports, SOPs), method validation/verification packages, and regulatory-ready content supporting potency for IND/IMPD and BLA/MAA submissions and post-approval changes.
Apply Quality by Design (QbD) and risk-based principles to define potency assay control strategy and critical method parameters, ensuring methods are scientifically justified, appropriately controlled, and scalable from early development through commercial QC.
Demonstrate fluency with ICH and global regulatory expectations for analytical methods (e.g., phase-appropriate validation/verification, comparability, and data integrity) and translate guidance into practical, compliant strategies for cell and gene therapy potency assays.
Stay at the forefront of potency assay technologies for cell and gene therapies, including CAR T functional assays (e.g., cytokine release, cytotoxicity, activation/proliferation) and viral vector potency (e.g., infectivity/transduction, expression-based readouts, ddPCR), as well as emerging platforms and associated analytical methodologies.
Provide strategic direction for potency assay selection and development (MOA alignment, assay formats, reference standards), troubleshooting, and data interpretation to support program and regulatory needs.
Lead high-impact CMC analytical projects, ensuring potency assay timelines and deliverables support stage-appropriate development through licensure and lifecycle management.
Embed a QC mindset in potency assay lifecycle management: enable routine release and stability execution through clear SOPs/training, system suitability and trending, and lead/support investigations (OOS/OOT/deviations), CAPA, and change control to maintain a compliant state.
Represent Analytical Operations in internal and external collaborations (QC, CDMOs/vendor labs), leading method transfer and ensuring compliance with cGMP and relevant compendial/industry standards.
Cultivate a culture of excellence, innovation, and cross-functional collaboration.
Basic Qualifications
Ph.D. or Advanced degree in Immunology, Cell Biology, Bioengineering, or related field with 8+ years of relevant industry experience
OR
Master’s degree in Immunology, Cell Biology, Bioengineering, or related field with 10+ years of relevant industry experience
OR
Bachelor’s degree in Immunology, Cell Biology, Bioengineering, or related field with 12+ years of relevant industry experience
Preferred Qualifications
Ph.D. or Advanced degree in Immunology, Cell Biology, Bioengineering, or related field with 12+ years of relevant industry experience.
5+ years of people leadership experience.
5+ years in QC or significant direct partnership with QC (e.g., validation activities).
Extensive expertise in potency assay development for cell and gene therapies, including MOA-driven strategy and execution of CAR T functional assays and viral vector potency approaches (infectivity/transduction and/or expression-based readouts), with complementary flow cytometry/molecular/biochemical methods as appropriate.
Experience in analytical method validation (including bioassays) and comparability/bridging strategies to support regulatory submissions (IND, BLA) and post-approval changes.
Solid grasp of cGMP and regulatory guidelines related to analytical methods for biologics, cell therapy, and gene therapy.
Demonstrated QC experience and mindset, including supporting GMP release/stability testing, method control strategy (standards/controls, system suitability), data integrity practices, and readiness for audits/inspections.
Commercial experience in assay development for late-stage clinical trials and commercial manufacturing.
Strong background in immunology/cell biology and functional assay development; experience with flow cytometry is a plus.
Proficiency in data analysis and visualization tools used for potency assays (e.g., dose–response/parallel line analysis and statistics) and, where applicable, flow cytometry analysis software such as FlowJo, FCS Express, and/or OMIQ.
Ability to interact with stakeholders to understand program needs, assay specifics, timelines, and data delivery.
Experience in working with vendor labs to transfer in-house assays and oversee external data quality.
Strong communication and scientific writing skills.
For additional benefits information, visit:
https://www.gilead.com/careers/compensation-benefits-and-wellbeing
* Eligible employees may participate in benefit plans, subject to the terms and conditions of the applicable plans.
Kite is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies with a goal of providing rapid, long-term durable response and eliminating the burden of chronic care. The company is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system's ability to recognize and kill tumors. Kite is based in Santa Monica, CA. For more information on Kite, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.
Kite Pharma is committed to providing equal employment opportunities to all employees and applicants for employment, and is dedicated to fostering an inclusive work environment comprised of diverse perspectives, backgrounds, and experiences. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, sex, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status, or other non-job related characteristics or other prohibited grounds specified in applicable federal, state and local laws. In order to ensure reasonable accommodation for individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans' Readjustment Act of 1974, and Title I of the Americans with Disabilities Act of 1990, applicants who require accommodation in the job application process may contact ApplicantAccommodations@gilead.com for assistance.
For more information about equal employment opportunity protections, please view the 'Know Your Rights' poster.
NOTICE: EMPLOYEE POLYGRAPH PROTECTION ACT
YOUR RIGHTS UNDER THE FAMILY AND MEDICAL LEAVE ACT
Kite Pharma will not discharge or in any other manner discriminate against employees or applicants because they have inquired about, discussed, or disclosed their own pay or the pay of another employee or applicant. However, employees who have access to the compensation information of other employees or applicants as a part of their essential job functions cannot disclose the pay of other employees or applicants to individuals who do not otherwise have access to compensation information, unless the disclosure is (a) in response to a formal complaint or charge, (b) in furtherance of an investigation, proceeding, hearing, or action, including an investigation conducted by the employer, (c) consistent with the legal duty to furnish information; or (d) otherwise protected by law.
Our environment respects individual differences and recognizes each employee as an integral member of our company. Our workforce reflects these values and celebrates the individuals who make up our growing team.
Kite Pharma provides a work environment free of harassment and prohibited conduct. We promote and support individual differences and diversity of thoughts and opinion.
Please apply via the Internal Career Opportunities portal in Workday.